UNC119B
gene geneOn this page
Also known as MGC5139POC7B
Summary
UNC119B (unc-119 lipid binding chaperone B, HGNC:16488) is a protein-coding gene on chromosome 12q24.31, encoding Protein unc-119 homolog B (A6NIH7). Myristoyl-binding protein that acts as a cargo adapter: specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization.
Enables lipid binding activity. Involved in cilium assembly and lipoprotein transport. Located in ciliary transition zone.
Source: NCBI Gene 84747 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_001080533
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16488 |
| Approved symbol | UNC119B |
| Name | unc-119 lipid binding chaperone B |
| Location | 12q24.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC5139, POC7B |
| Ensembl gene | ENSG00000175970 |
| Ensembl biotype | protein_coding |
| OMIM | 620513 |
| Entrez | 84747 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 nonsense_mediated_decay, 3 protein_coding, 1 retained_intron
ENST00000344651, ENST00000539658, ENST00000618898, ENST00000718081, ENST00000718082, ENST00000718083, ENST00000718084, ENST00000953441
RefSeq mRNA: 1 — MANE Select: NM_001080533
NM_001080533
CCDS: CCDS31914
Canonical transcript exons
ENST00000344651 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001369996 | 120716628 | 120716739 |
| ENSE00001383176 | 120716870 | 120717042 |
| ENSE00002249997 | 120710458 | 120710718 |
| ENSE00003692746 | 120713274 | 120713387 |
| ENSE00004034067 | 120719920 | 120723640 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.38.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.4529 / max 197.7089, expressed in 1815 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128380 | 29.2073 | 1814 |
| 128381 | 1.2456 | 910 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 93.38 | gold quality |
| right uterine tube | UBERON:0001302 | 93.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.45 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.08 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.91 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.69 | gold quality |
| fallopian tube | UBERON:0003889 | 91.37 | gold quality |
| adrenal gland | UBERON:0002369 | 90.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.70 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.17 | gold quality |
| pituitary gland | UBERON:0000007 | 89.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.71 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.07 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 89.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 88.80 | gold quality |
| thyroid gland | UBERON:0002046 | 88.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 88.63 | gold quality |
| kidney | UBERON:0002113 | 88.62 | gold quality |
| ovary | UBERON:0000992 | 88.61 | gold quality |
| left ovary | UBERON:0002119 | 88.49 | gold quality |
| pancreas | UBERON:0001264 | 88.47 | gold quality |
| stromal cell of endometrium | CL:0002255 | 88.28 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.01 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 87.87 | gold quality |
| body of uterus | UBERON:0009853 | 87.83 | gold quality |
| cortex of kidney | UBERON:0001225 | 87.70 | gold quality |
| right ovary | UBERON:0002118 | 87.62 | gold quality |
| myometrium | UBERON:0001296 | 87.47 | gold quality |
| hypothalamus | UBERON:0001898 | 87.32 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.86 |
| E-MTAB-2983 | no | 473.72 |
| E-MTAB-6379 | no | 59.83 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
129 targeting UNC119B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
Literature-anchored findings (GeneRIF, showing 1)
- Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. (PMID:37903971)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | unc119b | ENSDARG00000009629 |
| mus_musculus | Unc119b | ENSMUSG00000046562 |
| rattus_norvegicus | Mlec | ENSRNOG00000021725 |
| drosophila_melanogaster | unc-119 | FBGN0025549 |
| caenorhabditis_elegans | WBGENE00006843 |
Paralogs (1): UNC119 (ENSG00000109103)
Protein
Protein identifiers
Protein unc-119 homolog B — A6NIH7 (reviewed: A6NIH7)
All UniProt accessions (1): A6NIH7
UniProt curated annotations — full annotation on UniProt →
Function. Myristoyl-binding protein that acts as a cargo adapter: specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization. Binds myristoylated NPHP3 and plays a key role in localization of NPHP3 to the primary cilium membrane. Does not bind all myristoylated proteins. Probably plays a role in trafficking proteins in photoreceptor cells.
Subunit / interactions. Found in a complex with ARL3, RP2 and UNC119B; RP2 induces hydrolysis of GTP ARL3 in the complex, leading to the release of UNC119B. Interacts with NPHP3 (when myristoylated). Interacts with CYS1 (when myristoylated). Interacts with MACIR; interaction only takes place when UNC119B is not liganded with myristoylated proteins.
Subcellular location. Cell projection. Cilium.
Domain organisation. Adopts an immunoglobulin-like beta-sandwich fold forming a hydrophobic cavity that capture N-terminally myristoylated target peptides. Phe residues within the hydrophobic beta sandwich are required for myristate binding.
Similarity. Belongs to the PDE6D/unc-119 family.
RefSeq proteins (1): NP_001074002* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008015 | PDED_dom | Domain |
| IPR014756 | Ig_E-set | Homologous_superfamily |
| IPR037036 | PDED_dom_sf | Homologous_superfamily |
| IPR051519 | PDE6D_unc-119_myristoyl-bd | Family |
Pfam: PF05351
UniProt features (23 total): strand 9, helix 4, mutagenesis site 3, modified residue 2, initiator methionine 1, chain 1, turn 1, region of interest 1, binding site 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OK6 | X-RAY DIFFRACTION | 1.95 |
| 7OK7 | X-RAY DIFFRACTION | 3.15 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NIH7-F1 | 81.77 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 142
Post-translational modifications (2): 2, 24
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 144 | reduced binding to myristoylated proteins; when associated with a-148 and a-207. |
| 148 | reduced binding to myristoylated proteins; when associated with a-144 and a-207. |
| 207 | reduced binding to myristoylated proteins; when associated with a-144 and a-148. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5624138 | Trafficking of myristoylated proteins to the cilium |
MSigDB gene sets: 198 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, AMIT_EGF_RESPONSE_480_MCF10A, MODULE_379, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_LIPOPROTEIN_LOCALIZATION, FUJII_YBX1_TARGETS_DN, CAIRO_HEPATOBLASTOMA_UP, GOBP_CELL_PROJECTION_ORGANIZATION, MODULE_242, MCCLUNG_COCAIN_REWARD_4WK, MODULE_104, GOCC_MOTILE_CILIUM
GO Biological Process (5): nervous system development (GO:0007399), lipoprotein transport (GO:0042953), cilium assembly (GO:0060271), protein transport (GO:0015031), cell projection organization (GO:0030030)
GO Molecular Function (2): lipid binding (GO:0008289), protein binding (GO:0005515)
GO Cellular Component (4): cytosol (GO:0005829), cilium (GO:0005929), ciliary transition zone (GO:0035869), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Cargo trafficking to the periciliary membrane | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| binding | 2 |
| system development | 1 |
| protein transport | 1 |
| lipoprotein localization | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| cellular component organization | 1 |
| cytoplasm | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1825 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UNC119B | ARL3 | P36405 | 758 |
| UNC119B | NPHP3 | Q7Z494 | 745 |
| UNC119B | PDE6D | O43924 | 633 |
| UNC119B | GNAT1 | P11488 | 620 |
| UNC119B | CYS1 | Q717R9 | 552 |
| UNC119B | CCDC71 | Q8IV32 | 549 |
| UNC119B | ARL2 | P36404 | 548 |
| UNC119B | URB2 | Q14146 | 450 |
| UNC119B | ARL13B | Q3SXY8 | 447 |
| UNC119B | SRC | P12931 | 436 |
| UNC119B | CFAP36 | Q96G28 | 435 |
| UNC119B | FAM114A1 | Q8IWE2 | 433 |
| UNC119B | DNAAF19 | Q8IW40 | 388 |
| UNC119B | GRB2 | P29354 | 373 |
| UNC119B | N4BP3 | O15049 | 325 |
IntAct
53 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARL3 | UNC119B | psi-mi:“MI:0914”(association) | 0.730 |
| UNC119 | UNC119B | psi-mi:“MI:0914”(association) | 0.640 |
| NPHP3 | UNC119B | psi-mi:“MI:0914”(association) | 0.590 |
| UNC119B | NPHP3 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| PSKH2 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
| AVPI1 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
| PALD1 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
| LZTS2 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
| STK16 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
| GNAT1 | UNC119B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZFC3H1 | UNC119B | psi-mi:“MI:0914”(association) | 0.350 |
| PAPD5 | UNC119B | psi-mi:“MI:0914”(association) | 0.350 |
| ARL3 | psi-mi:“MI:0914”(association) | 0.350 | |
| NPHP3 | ARHGEF35 | psi-mi:“MI:0914”(association) | 0.350 |
| RNF34 | UNC119B | psi-mi:“MI:0914”(association) | 0.350 |
| RNASEL | UNC119B | psi-mi:“MI:0914”(association) | 0.350 |
| SLA2 | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (52): UNC119B (Affinity Capture-RNA), UNC119B (Affinity Capture-RNA), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Proximity Label-MS), UNC119B (Affinity Capture-MS)
ESM2 similar proteins: A0A1D6HQ92, A2WSZ6, A2XX39, A2ZVY5, A6NIH7, B4FR29, B9Q0C2, F4IVL6, O60291, P04294, P04413, P49727, P68350, Q05A36, Q07820, Q0J7T6, Q0JAI1, Q2QNS6, Q2QPW2, Q3UE17, Q42840, Q53JI9, Q53K52, Q58CZ0, Q5R4R7, Q5VM82, Q5VRL3, Q6IMP4, Q6L5G1, Q6UDF4, Q6UDI9, Q6UDL6, Q6ZBS8, Q750B5, Q75CM4, Q7XDY9, Q7XLY8, Q7YRZ9, Q80TL4, Q84MH1
Diamond homologs: A6NIH7, O19177, Q10658, Q13432, Q17297, Q3SYR2, Q62885, Q66JA9, Q6INE2, Q8C4B4, Q90Z08, Q9XYQ2, Q9Z2R6, O55057, Q95142, Q9XT54, O43924
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
767 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:120710715:GAGA:G | donor_gain | 1.0000 |
| 12:120710716:AGA:A | donor_gain | 1.0000 |
| 12:120710717:GA:G | donor_gain | 1.0000 |
| 12:120710717:GAG:G | donor_gain | 1.0000 |
| 12:120710719:G:GG | donor_gain | 1.0000 |
| 12:120713265:T:TA | acceptor_gain | 1.0000 |
| 12:120713269:TTCA:T | acceptor_loss | 1.0000 |
| 12:120713270:TCAG:T | acceptor_loss | 1.0000 |
| 12:120713272:A:AG | acceptor_gain | 1.0000 |
| 12:120713272:A:C | acceptor_loss | 1.0000 |
| 12:120713273:G:GC | acceptor_gain | 1.0000 |
| 12:120713273:GA:G | acceptor_gain | 1.0000 |
| 12:120713273:GAT:G | acceptor_gain | 1.0000 |
| 12:120713273:GATT:G | acceptor_gain | 1.0000 |
| 12:120713273:GATTA:G | acceptor_gain | 1.0000 |
| 12:120713350:G:T | donor_gain | 1.0000 |
| 12:120713385:CAG:C | donor_loss | 1.0000 |
| 12:120713386:AGG:A | donor_loss | 1.0000 |
| 12:120713387:GGTA:G | donor_loss | 1.0000 |
| 12:120713388:G:T | donor_loss | 1.0000 |
| 12:120713389:T:G | donor_loss | 1.0000 |
| 12:120716623:TTCA:T | acceptor_loss | 1.0000 |
| 12:120716626:A:AG | acceptor_gain | 1.0000 |
| 12:120716627:G:A | acceptor_loss | 1.0000 |
| 12:120716627:G:GA | acceptor_gain | 1.0000 |
| 12:120716627:GA:G | acceptor_gain | 1.0000 |
| 12:120716627:GAC:G | acceptor_gain | 1.0000 |
| 12:120716627:GACC:G | acceptor_gain | 1.0000 |
| 12:120716733:GGGC:G | donor_gain | 1.0000 |
| 12:120716734:GGC:G | donor_gain | 1.0000 |
AlphaMissense
1651 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:120710692:T:A | V73D | 1.000 |
| 12:120713280:T:C | L84S | 1.000 |
| 12:120713283:G:A | C85Y | 1.000 |
| 12:120713284:T:G | C85W | 1.000 |
| 12:120713299:C:A | N90K | 1.000 |
| 12:120713299:C:G | N90K | 1.000 |
| 12:120713310:T:A | I94N | 1.000 |
| 12:120713315:T:C | F96L | 1.000 |
| 12:120713315:T:G | F96V | 1.000 |
| 12:120713316:T:C | F96S | 1.000 |
| 12:120713316:T:G | F96C | 1.000 |
| 12:120713317:C:A | F96L | 1.000 |
| 12:120713317:C:G | F96L | 1.000 |
| 12:120713322:G:C | R98P | 1.000 |
| 12:120713324:T:A | F99I | 1.000 |
| 12:120713324:T:C | F99L | 1.000 |
| 12:120713324:T:G | F99V | 1.000 |
| 12:120713325:T:C | F99S | 1.000 |
| 12:120713325:T:G | F99C | 1.000 |
| 12:120713326:C:A | F99L | 1.000 |
| 12:120713326:C:G | F99L | 1.000 |
| 12:120713331:T:A | I101N | 1.000 |
| 12:120713331:T:C | I101T | 1.000 |
| 12:120713331:T:G | I101S | 1.000 |
| 12:120713334:G:C | R102P | 1.000 |
| 12:120713358:T:A | L110H | 1.000 |
| 12:120713358:T:C | L110P | 1.000 |
| 12:120713360:T:A | F111I | 1.000 |
| 12:120713360:T:C | F111L | 1.000 |
| 12:120713360:T:G | F111V | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000043490 (12:120712296 A>G), RS1000254956 (12:120715500 T>A), RS1000500753 (12:120718215 T>G), RS1000614 (12:120711137 C>G,T), RS1000615 (12:120711372 C>A,T), RS1000858810 (12:120717120 G>T), RS1001006806 (12:120722776 C>G), RS1001090512 (12:120716290 T>C), RS1001530881 (12:120714293 T>C), RS1001565429 (12:120712869 AGTTGGCAAACTAAC>A), RS1001608994 (12:120713729 C>G), RS1002014842 (12:120714615 G>A), RS1002133046 (12:120720986 A>G), RS1003237251 (12:120721887 G>A,T), RS1003493853 (12:120712190 T>G)
Disease associations
OMIM: gene MIM:620513 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004602_163 | Mean corpuscular volume | 6.000000e-45 |
| GCST004630_188 | Mean corpuscular hemoglobin | 3.000000e-39 |
| GCST006249_30 | Serum metabolite levels | 4.000000e-177 |
| GCST006804_116 | Red cell distribution width | 7.000000e-17 |
| GCST012020_372 | Serum metabolite levels | 1.000000e-31 |
| GCST012353_6 | Serum metabolite concentrations in chronic kidney disease | 5.000000e-14 |
| GCST90002390_74 | Mean corpuscular hemoglobin | 9.000000e-119 |
| GCST90002392_394 | Mean corpuscular volume | 4.000000e-154 |
| GCST90002396_538 | Mean reticulocyte volume | 6.000000e-139 |
| GCST90002397_219 | Mean spheric corpuscular volume | 9.000000e-116 |
| GCST90002403_461 | Red blood cell count | 8.000000e-63 |
| GCST90002404_146 | Red cell distribution width | 2.000000e-41 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0009188 | Red cell distribution width |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| clothianidin | increases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Diuron | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.